Analyst Shawn Egan works at CITI and is covering the the Healthcare sector with 4 price targets and ratings documented since 2020 spanning on 1 stocks.
Shawn Egan's average stock forecast success ratio is 50% with an average time for price targets to be met of 78 days.
Most recent stock forecast was given on ARWR, Arrowhead Pharmaceuticals, Inc at 08-Feb-2021.
Analyst best performing recommendations are on ARWR (ARROWHEAD PHARMACEUTICALS, INC).
The best stock recommendation documented was for ARWR (ARROWHEAD PHARMACEUTICALS, INC) at 11/19/2020. The price target of $90 was fulfilled within 78 days with a profit of $21.08 (30.59%) receiving and performance score of 3.92.
Average potential price target upside
Currently, out of the existing stock ratings of Shawn Egan - 2 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
60
$25.59 (74.37%)
60
8 days ago
6/12 (50%)
$17.17 (49.71%)
183
Buy
40
$5.59 (16.25%)
35
20 days ago
11/12 (91.67%)
$-8.2 (-13.11%)
131
Buy
90
$55.59 (161.55%)
90
3 months 22 days ago
0/5 (0%)
$46.67 (127.37%)
Buy
55
$20.59 (59.84%)
59
3 months 24 days ago
9/15 (60%)
$21.4 (46.97%)
129
Buy
52
$17.59 (51.12%)
55
3 months 25 days ago
21/32 (65.63%)
$18.37 (50.58%)
159
